Search Results - "Tamm, Eric P"

Image Quality Assessment of Abdominal CT by Use of New Deep Learning Image Reconstruction: Initial Experience by Jensen, Corey T, Liu, Xinming, Tamm, Eric P, Chandler, Adam G, Sun, Jia, Morani, Ajaykumar C, Javadi, Sanaz, Wagner-Bartak, Nicolaus A

“…The purpose of this study was to perform quantitative and qualitative evaluation of a deep learning image reconstruction (DLIR) algorithm in contrast-enhanced…”
Get full text

Intermanufacturer Comparison of Dual-Energy CT Iodine Quantification and Monochromatic Attenuation: A Phantom Study by Jacobsen, Megan C, Schellingerhout, Dawid, Wood, Cayla A, Tamm, Eric P, Godoy, Myrna C, Sun, Jia, Cody, Dianna D

“…Purpose To determine the accuracy of dual-energy computed tomographic (CT) quantitation in a phantom system comparing fast kilovolt peak-switching,…”
Get full text

Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association by Al-Hawary, Mahmoud M., MD, Francis, Isaac R., MD, Chari, Suresh T., MD, Fishman, Elliot K., MD, Hough, David M., MD, Lu, David S., MD, Macari, Michael, MD, Megibow, Alec J., MD, Miller, Frank H., MD, Mortele, Koenraad J., MD, Merchant, Nipun B., MD, Minter, Rebecca M., MD, Tamm, Eric P., MD, Sahani, Dushyant V., MD, Simeone, Diane M., MD

“…Pancreatic ductal adenocarcinoma is an aggressive malignancy with a high mortality rate. Proper determination of the extent of disease on imaging studies at…”
Get full text

Dual-Energy CT: Lower Limits of Iodine Detection and Quantification by Jacobsen, Megan C, Cressman, Erik N K, Tamm, Eric P, Baluya, Dodge L, Duan, Xinhui, Cody, Dianna D, Schellingerhout, Dawid, Layman, Rick R

“…Background Assessments of the quantitative limitations among the six commercially available dual-energy (DE) CT acquisition schemes used by major CT…”
Get full text

Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association by Al-Hawary, Mahmoud M, Francis, Isaac R, Chari, Suresh T, Fishman, Elliot K, Hough, David M, Lu, David S, Macari, Michael, Megibow, Alec J, Miller, Frank H, Mortele, Koenraad J, Merchant, Nipun B, Minter, Rebecca M, Tamm, Eric P, Sahani, Dushyant V, Simeone, Diane M

“…Pancreatic ductal adenocarcinoma is an aggressive malignancy with a high mortality rate. Proper determination of the extent of disease on imaging studies at…”
Get full text

Transport properties of pancreatic cancer describe gemcitabine delivery and response by Koay, Eugene J, Truty, Mark J, Cristini, Vittorio, Thomas, Ryan M, Chen, Rong, Chatterjee, Deyali, Kang, Ya'an, Bhosale, Priya R, Tamm, Eric P, Crane, Christopher H, Javle, Milind, Katz, Matthew H, Gottumukkala, Vijaya N, Rozner, Marc A, Shen, Haifa, Lee, Jeffery E, Wang, Huamin, Chen, Yuling, Plunkett, William, Abbruzzese, James L, Wolff, Robert A, Varadhachary, Gauri R, Ferrari, Mauro, Fleming, Jason B

“…The therapeutic resistance of pancreatic ductal adenocarcinoma (PDAC) is partly ascribed to ineffective delivery of chemotherapy to cancer cells. We…”
Get full text

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head by VARADHACHARY, Gauri R, WOLFF, Robert A, LEE, Jeffrey H, ROSS, William A, TAMM, Eric P, BHOSALE, Priya R, KRISHNAN, Sunil, DAS, Prajnan, HO, Linus, XIONG, Henry, ABBRUZZESE, James L, EVANS, Douglas B, CRANE, Christopher H, SUN, Charlotte C, LEE, Jeffrey E, PISTERS, Peter W. T, VAUTHEY, Jean-Nicolas, ABDALLA, Eddie, HUAMIN WANG, STAERKEL, Gregg A

“…We conducted a phase II trial of preoperative gemcitabine and cisplatin chemotherapy in addition to chemoradiation (Gem-Cis-XRT) and pancreaticoduodenectomy…”
Get full text

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy by Varadhachary, Gauri R, Tamm, Eric P, Abbruzzese, James L, Xiong, Henry Q, Crane, Christopher H, Wang, Huamin, Lee, Jeffrey E, Pisters, Peter W T, Evans, Douglas B, Wolff, Robert A

“…With recent advances in pancreatic imaging and surgical techniques, a distinct subset of pancreatic tumors is emerging that blurs the distinction between…”
Get full text

Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT by Wang, Wei, MD, Shpaner, Alexander, MD, Krishna, Somashekar G., MD, MPH, Ross, William A., MD, MBA, Bhutani, Manoop S., MD, Tamm, Eric P., MD, Raju, Gottumukkala S., MD, Xiao, Lianchun, MS, Wolff, Robert A., MD, Fleming, Jason B., MD, Lee, Jeffrey H., MD, MPH

“…Background Diagnosis of pancreatic neoplasm is challenging in patients with inconclusive findings on pancreatic multidetector row CT (MDCT). Objective To…”
Get full text

PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer by Douglas, Julia E, Liu, Suyu, Ma, Junsheng, Wolff, Robert A, Pant, Shubham, Maitra, Anirban, Tamm, Eric P, Bhosale, Priya, Katz, Matthew H G, Varadhachary, Gauri R, Koay, Eugene J

“…Personalized and effective treatments for pancreatic ductal adenocarcinoma (PDAC) continue to remain elusive. Novel clinical trial designs that enable…”
Get full text

Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease by Soloff, Erik V., Zaheer, Atif, Meier, Jeffrey, Zins, Marc, Tamm, Eric P.

“…Pancreatic ductal adenocarcinoma (PDAC) is a relatively common malignancy that carries an overall poor prognosis, with five-year survival below 10%. Despite…”
Get full text

Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy by Amer, Ahmed M., Zaid, Mohamed, Chaudhury, Baishali, Elganainy, Dalia, Lee, Yeonju, Wilke, Christopher T., Cloyd, Jordan, Wang, Huamin, Maitra, Anirban, Wolff, Robert A., Varadhachary, Gauri, Overman, Michael J., Lee, Jeffery E., Fleming, Jason B., Tzeng, Ching Wei, Katz, Matthew H., Holliday, Emma B., Krishnan, Sunil, Minsky, Bruce D., Herman, Joseph M., Taniguchi, Cullen M., Das, Prajnan, Crane, Christopher H., Le, Ott, Bhosale, Priya, Tamm, Eric P., Koay, Eugene J.

“…BACKGROUND The assessment of pancreatic ductal adenocarcinoma (PDAC) response to therapy remains challenging. The objective of this study was to investigate…”
Get full text

Significance of T1a and T1b Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas by Hui, Ling, Rashid, Asif, Foo, Wai Chin, Katz, Matthew H, Chatterjee, Deyali, Wang, Hua, Fleming, Jason B, Tamm, Eric P, Wang, Huamin

“…Mucinous cystic neoplasm (MCN) of pancreas is one of the precursor lesions of pancreatic ductal adenocarcinoma. The 5-year disease-specific survival for…”
Get full text

White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals by Kulkarni, Naveen M., Mannelli, Lorenzo, Zins, Marc, Bhosale, Priya R., Arif-Tiwari, Hina, Brook, Olga R., Hecht, Elizabeth M., Kastrinos, Fay, Wang, Zhen Jane, Soloff, Erik V., Tolat, Parag P., Sangster, Guillermo, Fleming, Jason, Tamm, Eric P., Kambadakone, Avinash R.

“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive gastrointestinal malignancy with a poor 5-year survival rate. Its high mortality rate is attributed to…”
Get full text

CT features predictive of nodal positivity at surgery in pancreatic cancer patients following neoadjuvant therapy in the setting of dual energy CT by Le, Ott, Javadi, Sanaz, Bhosale, Priya R., Koay, Eugene J., Katz, Matthew H., Sun, Jia, Yang, Wei, Tamm, Eric P.

“…Purpose Evaluate utility of dual energy CT iodine material density images to identify preoperatively nodal positivity in pancreatic cancer patients who…”
Get full text

State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors by Tamm, Eric P., MD, Bhosale, Priya, MD, Lee, Jeffrey H., MD, Rohren, Eric M., MD, PhD

“…Pancreatic neuroendocrine tumors are rare tumors that present many imaging challenges, from detecting small functional tumors to fully staging large…”
Get full text

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience by Bagley, Alexander F., Ludmir, Ethan B., Maitra, Anirban, Minsky, Bruce D., Li Smith, Grace, Das, Prajnan, Koong, Albert C., Holliday, Emma B., Taniguchi, Cullen M., Katz, Matthew H.G., Tamm, Eric P., Wolff, Robert A., Overman, Michael J., Patel, Shivani, Kim, Michael P., Tzeng, Ching-Wei D., Ikoma, Naruhiko, Bhutani, Manoop S., Koay, Eugene J.

“…•NBTXR3 is a radioenhancer composed of functionalized hafnium oxide nanoparticles.•This report describes the first patient with pancreatic cancer treated with…”
Get full text

Imaging of Pancreatic Adenocarcinoma: Update on Staging/Resectability by Tamm, Eric P., MD, Balachandran, Aparna, MD, Bhosale, Priya R., MD, Katz, Matthew H., MD, Fleming, Jason B., MD, Lee, Jeffrey H., MD, Varadhachary, Gauri R., MD

“…Because of the evolution of treatment strategies staging criteria for pancreatic cancer now emphasize arterial involvement for determining unresectable…”
Get full text

EUS-FNA for Pancreatic Neuroendocrine Tumors: A Tertiary Cancer Center Experience by Atiq, Muslim, Bhutani, Manoop S., Bektas, Mehmet, Lee, Jeffrey E., Gong, Yun, Tamm, Eric P., Shah, Chintan P., Ross, William A., Yao, James, Raju, Gottumukkala S., Wang, Xuemei, Lee, Jeffrey H.

“…Objectives Pancreatic neuroendocrine tumors (PNET) are fairly uncommon. Recent data highlight the importance of EUS in diagnosis of PNET. With this background,…”
Get full text

Introduction to Guest Section on Neuroendocrine Tumors by Tamm, Eric P

Get full text